114 related articles for article (PubMed ID: 10893435)
1. Transduction effect of antisense K-ras on malignant phenotypes in gastric cancer cells.
Song JJ; Lee H; Kim E; Kim YS; Yoo NC; Roh JK; Kim BS; Kim J
Cancer Lett; 2000 Aug; 157(1):1-7. PubMed ID: 10893435
[TBL] [Abstract][Full Text] [Related]
2. Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype.
Zhang Y; Mukhopadhyay T; Donehower LA; Georges RN; Roth JA
Hum Gene Ther; 1993 Aug; 4(4):451-60. PubMed ID: 8399492
[TBL] [Abstract][Full Text] [Related]
3. Identification of genes showing differential expression in antisense K-ras-transduced pancreatic cancer cells with suppressed tumorigenicity.
Ohnami S; Matsumoto N; Nakano M; Aoki K; Nagasaki K; Sugimura T; Terada M; Yoshida T
Cancer Res; 1999 Nov; 59(21):5565-71. PubMed ID: 10554036
[TBL] [Abstract][Full Text] [Related]
4. Suppression of colorectal cancer growth using an adenovirus vector expressing an antisense K-ras RNA.
Nakano M; Aoki K; Matsumoto N; Ohnami S; Hatanaka K; Hibi T; Terada M; Yoshida T
Mol Ther; 2001 Apr; 3(4):491-9. PubMed ID: 11319909
[TBL] [Abstract][Full Text] [Related]
5. Liposome-mediated in vivo gene transfer of antisense K-ras construct inhibits pancreatic tumor dissemination in the murine peritoneal cavity.
Aoki K; Yoshida T; Sugimura T; Terada M
Cancer Res; 1995 Sep; 55(17):3810-6. PubMed ID: 7641198
[TBL] [Abstract][Full Text] [Related]
6. Oligonucleotide treatment of ras-induced tumors in nude mice.
Wickstrom E
Mol Biotechnol; 2001 May; 18(1):35-55. PubMed ID: 11439698
[TBL] [Abstract][Full Text] [Related]
7. P21 protein expression and ras-oncogene mutations in gastric carcinoma: correlation with clinical data.
Kasper HU; Schneider-Stock R; Mellin W; Roessner A
Int J Oncol; 1998 Jan; 12(1):69-74. PubMed ID: 9454888
[TBL] [Abstract][Full Text] [Related]
8. Suppression of Ki-ras p21 levels leading to growth inhibition of pancreatic cancer cell lines with Ki-ras mutation but not those without Ki-ras mutation.
Aoki K; Yoshida T; Matsumoto N; Ide H; Sugimura T; Terada M
Mol Carcinog; 1997 Oct; 20(2):251-8. PubMed ID: 9364215
[TBL] [Abstract][Full Text] [Related]
9. K-ras mutation in helicobacter pylori-associated chronic gastritis in patients with and without gastric cancer.
Hiyama T; Haruma K; Kitadai Y; Masuda H; Miyamoto M; Tanaka S; Yoshihara M; Shimamoto F; Chayama K
Int J Cancer; 2002 Feb; 97(5):562-6. PubMed ID: 11807778
[TBL] [Abstract][Full Text] [Related]
10. Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA.
Mukhopadhyay T; Tainsky M; Cavender AC; Roth JA
Cancer Res; 1991 Mar; 51(6):1744-8. PubMed ID: 1998965
[TBL] [Abstract][Full Text] [Related]
11. Establishment and characterization of human gastric carcinoma cell lines.
Park JG; Yang HK; Kim WH; Chung JK; Kang MS; Lee JH; Oh JH; Park HS; Yeo KS; Kang SH; Song SY; Kang YK; Bang YJ; Kim YH; Kim JP
Int J Cancer; 1997 Feb; 70(4):443-9. PubMed ID: 9033653
[TBL] [Abstract][Full Text] [Related]
12. Transcription inhibition of oncogenic KRAS by a mutation-selective peptide nucleic acid conjugated to the PKKKRKV nuclear localization signal peptide.
Cogoi S; Codognotto A; Rapozzi V; Meeuwenoord N; van der Marel G; Xodo LE
Biochemistry; 2005 Aug; 44(31):10510-9. PubMed ID: 16060660
[TBL] [Abstract][Full Text] [Related]
13. Prevention of orthotopic human lung cancer growth by intratracheal instillation of a retroviral antisense K-ras construct.
Georges RN; Mukhopadhyay T; Zhang Y; Yen N; Roth JA
Cancer Res; 1993 Apr; 53(8):1743-6. PubMed ID: 8467490
[TBL] [Abstract][Full Text] [Related]
14. Mutation of ras oncogene in gastric adenocarcinoma: association with histological phenotype.
Kim TY; Bang YJ; Kim WS; Kang SH; Lee KU; Choe KJ; Kim NK
Anticancer Res; 1997; 17(2B):1335-9. PubMed ID: 9137494
[TBL] [Abstract][Full Text] [Related]
15. [Inhibition of antisense DNA and its derivative on gastric transformed cell carcinogenicity].
Yang D; Li T; Xu W
Zhonghua Wai Ke Za Zhi; 1995 Jan; 33(1):26-8. PubMed ID: 7774440
[TBL] [Abstract][Full Text] [Related]
16. [Detection of ras gene mutation in various stages of gastric cancer by PCR/RFLP SSCP and DNA sequencing].
Hao Y; Zhang J; Lu Y
Zhonghua Nei Ke Za Zhi; 1997 Sep; 36(9):595-8. PubMed ID: 10436968
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibitory effect of anti-K-ras adenovirus on lung cancer cells.
Alemany R; Ruan S; Kataoka M; Koch PE; Mukhopadhyay T; Cristiano RJ; Roth JA; Zhang WW
Cancer Gene Ther; 1996; 3(5):296-301. PubMed ID: 8894248
[TBL] [Abstract][Full Text] [Related]
18. Expression profiles of pancreatic cancer cell lines infected with antisense K-ras-expressing adenoviral vector.
Ohnami S; Aoki K; Yoshida K; Ohnami S; Hatanaka K; Suzuki K; Sasaki H; Yoshida T
Biochem Biophys Res Commun; 2003 Oct; 309(4):798-803. PubMed ID: 13679043
[TBL] [Abstract][Full Text] [Related]
19. The role of ras gene mutation in gastric cancer and precancerous lesions.
Hao Y; Zhang J; Lu Y; Yi C; Qian W; Cui J
J Tongji Med Univ; 1998; 18(3):141-4. PubMed ID: 10806811
[TBL] [Abstract][Full Text] [Related]
20. Inhibited neoplastic phenotype by the c-Ha-ras antisense RNA.
Lu GR; Wu CJ; Ke Y; Xiong X; Li YJ; Liu JM; Xu Y; Xu W; Li JY; Deng GR
Sci China B; 1991 Dec; 34(12):1485-91. PubMed ID: 1801843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
